In a new study published in The Lancet Infectious Diseases, a team of University of Minnesota researchers found that metformin, a drug commonly used to treat diabetes, prevents the development of long COVID. Former KL2 scholar Carolyn Bramante, MD, is the principal investigator.
Other News
We are delighted to extend a heartfelt welcome to President Rebecca Cunningham.
Communities of practice brings together individuals with shared interests or passions.
Through Project REACH, Ben Cahill worked on increasing housing opportunities for individuals facing chronic health conditions in…